Findings From World Mental Health Surveys of the Perceived Helpfulness of Treatment for Patients With Major Depressive Disorder.

Journal: JAMA psychiatry

Volume: 77

Issue: 8

Year of Publication: 2021

Affiliated Institutions:  The University of Queensland School of Public Health, Herston, Queensland, Australia. Department of Psychology, Yale University, New Haven, Connecticut. Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts. Center for Reducing Health Disparities, UC Davis Health System, Sacramento, California. Al-Qadisiya University College of Medicine, Diwaniya Governorate, Iraq. IMIM-Hospital del Mar Research Institute, Parc de Salut Mar, Barcelona, Spain. Epidemiology Section, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Núcleo de Epidemiologia Psiquiátrica (LIM ), Instituto de Psiquiatria Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. Lisbon Institute of Global Mental Health and Chronic Diseases Research Center, NOVA Medical School, NOVA University of Lisbon, Lisbon, Portugal. Anxiety Disorders Center, Buenos Aires, Argentina. National School of Public Health, Management and Development, Bucharest, Romania. Department of Psychiatry, University College Hospital, Ibadan, Nigeria. Shenzhen Institute of Mental Health, Shenzhen Kangning Hospital, Shenzhen, China. Department of Psychiatry and Clinical Psychology, Faculty of Medicine, Balamand University, Beirut, Lebanon. Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor. UDIF-SM, Subdirección General de Planificación, Innovación y Cronicidad, Servicio Murciano de Salud, IMIB-Arrixaca, CIBERESP-Murcia, Murcia, Spain. Ulster University School of Psychology, Londonderry, United Kingdom. Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand. The Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, Sydney, New South Wales, Australia. Center for Excellence on Research in Mental Health, CES University, Medellín, Colombia. Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada. National Institute of Public Health-National Institute of Hygiene, Warsaw, Poland. National Center of Public Health and Analyses, Directorate of Mental Health and Prevention of Addictions, Sofia, Bulgaria. Mental Health Services, Israeli Ministry of Health, Jerusalem, Israel.

Abstract summary 

The perceived helpfulness of treatment is an important patient-centered measure that is a joint function of whether treatment professionals are perceived as helpful and whether patients persist in help-seeking after previous unhelpful treatments.To examine the prevalence and factors associated with the 2 main components of perceived helpfulness of treatment in a representative sample of individuals with a lifetime history of DSM-IV major depressive disorder (MDD).This study examined the results of a coordinated series of community epidemiologic surveys of noninstitutionalized adults using the World Health Organization World Mental Health surveys. Seventeen surveys were conducted in 16 countries (8 surveys in high-income countries and 9 in low- and middle-income countries). The dates of data collection ranged from 2002 to 2003 (Lebanon) to 2016 to 2017 (Bulgaria). Participants included those with a lifetime history of treated MDD. Data analyses were conducted from April 2019 to January 2020. Data on socioeconomic characteristics, lifetime comorbid conditions (eg, anxiety and substance use disorders), treatment type, treatment timing, and country income level were collected.Conditional probabilities of helpful treatment after seeing between 1 and 5 professionals; persistence in help-seeking after between 1 and 4 unhelpful treatments; and ever obtaining helpful treatment regardless of number of professionals seen.Survey response rates ranged from 50.4% (Poland) to 97.2% (Medellín, Columbia), with a pooled response rate of 68.3% (n = 117 616) across surveys. Mean (SE) age at first depression treatment was 34.8 (0.3) years, and 69.4% were female. Of 2726 people with a lifetime history of treatment of MDD, the cumulative probability (SE) of all respondents pooled across countries of helpful treatment after seeing up to 10 professionals was 93.9% (1.2%), but only 21.5% (3.2%) of patients persisted that long (ie, beyond 9 unhelpful treatments), resulting in 68.2% (1.1%) of patients ever receiving treatment that they perceived as helpful. The probability of perceiving treatment as helpful increased in association with 4 factors: older age at initiating treatment (adjusted odds ratio [AOR], 1.02; 95% CI, 1.01-1.03), higher educational level (low: AOR, 0.48; 95% CI, 0.33-0.70; low-average: AOR, 0.62; 95% CI, 0.44-0.89; high average: AOR, 0.67; 95% CI, 0.49-0.91 vs high educational level), shorter delay in initiating treatment after first onset (AOR, 0.98; 95% CI, 0.97-0.99), and medication received from a mental health specialist (AOR, 2.91; 95% CI, 2.04-4.15). Decomposition analysis showed that the first 2 of these 4 factors were associated with only the conditional probability of an individual treatment professional being perceived as helpful (age at first depression treatment: AOR, 1.02; 95% CI, 1.01-1.02; educational level: low: AOR, 0.48; 95% CI, 0.33-0.70; low-average: AOR, 0.62; 95% CI, 0.44-0.89; high-average: AOR, 0.67; 95% CI, 0.49-0.91 vs high educational level), whereas the latter 2 factors were associated with only persistence (treatment delay: AOR, 0.98; 95% CI, 0.97-0.99; treatment type: AOR, 3.43; 95% CI, 2.51-4.70).The probability that patients with MDD obtain treatment that they consider helpful might increase, perhaps markedly, if they persisted in help-seeking after unhelpful treatments with up to 9 prior professionals.

Authors & Co-authors:  Harris Meredith G MG Kazdin Alan E AE Chiu Wai Tat WT Sampson Nancy A NA Aguilar-Gaxiola Sergio S Al-Hamzawi Ali A Alonso Jordi J Altwaijri Yasmin Y Andrade Laura Helena LH Cardoso Graça G Cía Alfredo A Florescu Silvia S Gureje Oye O Hu Chiyi C Karam Elie G EG Karam Georges G Mneimneh Zeina Z Navarro-Mateu Fernando F Oladeji Bibilola D BD O'Neill Siobhan S Scott Kate K Slade Tim T Torres Yolanda Y Vigo Daniel D Wojtyniak Bogdan B Zarkov Zahari Z Ziv Yuval Y Kessler Ronald C RC

Study Outcome 

Source Link: Visit source

Statistics
Citations :  GBD 2017 DALYs and HALE Collaborators Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859-1922. doi:10.1016/S0140-6736(18)32335-3
Authors :  29
Identifiers
Doi : 10.1001/jamapsychiatry.2020.1107
SSN : 2168-6238
Study Population
Male,Female
Mesh Terms
Adolescent
Other Terms
Study Design
Cross Sectional Study
Study Approach
Country of Study
Publication Country
United States